|
| Study population (n = 62) | Long-term effective ablation (n = 19) | Long-term partially successful ablation (n = 15) | Long-term ineffective ablation (n = 13) | value |
|
hsTnI, ng/mL (normal range: <0.0156 for women; <0.0342 for man) | 0.053 (0.029–0.150) | 0.037 (0.023–0.117) | 0.048 (0.030–0.096) | 0.079 (0.036–0.199) | 0.308 |
CK-MB, ng/mL (normal range: <3.1) | 1.4 (0.9–2.6) | 1.0 (0.7–1.3) | 2.6 (1.5–4.0) | 1.4 (1.2–1.5) | 0.027 |
BNP before RFA, pg/mL (normal range: <159) | 261 (145–728) | 146 (67–220) | 330 (156–365) | 1029 (255–1677) | 0.004 |
BNP at hospital discharge, pg/mL (normal range: <159) | 354 (176–495) | 135 (129–156) | 302 (190–393) | 369 (242–408) | 0.029 |
Creatinine, mg/dL (normal range: 0.55–1.02) | 1.17 (1.0–1.47) | 1.06 (0.94–1.19) | 1.22 (1.0–1.37) | 1.26 (1.12–1.29) | 0.417 |
Potassium, mmol/L (normal range: 3.5–5.1) | 4.3 (4.0–4.5) | 4.4 (4.1–4.8) | 4.2 (4.0–4.4) | 4.2 (4.0–4.6) | 0.209 |
CRP, mg/L (normal range: <5.0) | 3.4 (1.2–13.3) | 2.6 (1.2–7.8) | 4.7 (1.6–32.3) | 1.5 (0.6–14.9) | 0.419 |
Neutrophils × 109/L (normal range: 2.0–7.0) | 4.9 (3.6–6.6) | 4.7 (3.5–6.5) | 4.7 (3.4–5.5) | 5.3 (4.5–6.4) | 0.528 |
Lymphocytes × 109/L (normal range: 1.0–3.0) | 1.7 (1.2–2.3) | 1.8 (1.5–2.6) | 1.5 (1.1–1.8) | 1.7 (0.7–1.9) | 0.064 |
NLR (normal range: 1–3) | 3.1 (1.9–4.5) | 2.3 (1.8–4.0) | 3.2 (2.2–4.8) | 3.7 (2.3–6.5) | 0.145 |
Hemoglobin, g/dL (normal range: 12.0–15.0) | 13.4 (12.2–14.5) | 13.9 (12.6–14.6) | 13.6 (12.3–14.5) | 12.5 (12.0–14.2) | 0.490 |
Platelets × 109/l (normal range: 150–410) | 203 (172–241) | 212 (189–250) | 219 (197–338) | 177 (170–187) | 0.014 |
TSH, uU/mL (normal range: 0.35–4.94) | 1.7 (0.8–2.9) | 2.2 (0.9–3.5) | 2.4 (0.9–3.3) | 1.8 (0.7–2.0) | 0.545 |
FT4, pmol/L (normal range: 9.01-19.05) | 15.3 (13.4–16.4) | 14.6 (13.6–15.4) | 15.3 (15.2–16.3) | 15.5 (14.6–18.1) | 0.428 |
ALT, UL (normal range: 5–34) | 25 (19–37) | 23 (19–26) | 41 (25–51) | 26 (14–59) | 0.116 |
AST, U/L (normal range: <55) | 24 (18–29) | 21 (16–24) | 33 (28–46) | 26 (21–33) | 0.003 |
|